Table 1 Demographic data of hospice ward admission patients

Sex

 Male (number, %)

86

54%

 Female (number, %)

74

46%

Age (mean, SD)

65.8

11.5

Age >  = 65 years old (number, %)

101

59.1%

Charlson comorbidity index (mean, SD)

9.54

2.35

Palliative prognostic index (mean, SD)

7.23

3.74

Palliative prognostic score (mean, SD)

11.40

4.74

Survival days since hospice ward admission (mean, SD)

16.8

23.7

Hospice ward hospitalization days (mean, SD)

10.5

14.1

Cancer Sites

 Hepatobiliary cancer (number, %)

36

22.5%

 Urogenital system cancer (number, %)

19

11.9%

 Breast cancer (number, %)

12

7.5%

 Colorectal cancer (number, %)

17

10.6%

 Lung cancer (number, %)

19

11.9%

 Esophageal and Gastric cancer (number, %)

18

11.3%

 Head and Neck cancer (number, %)

19

11.9%

 Others (number, %)

20

12.5%

Cancer Metastases sites

 No distant metastases (number, %)

19

11.9%

 1–2 metastases sites (number, %)

79

49.4%

 More than 3 metastases sites (number, %)

62

38.8%

 Brain metastases (number, %)

17

10.6%

 Lymph node metastases (number, %)

80

50%

 Lung metastases (number, %)

67

42.1%

 Liver metastases (number, %)

63

39.4

 Bone metastases (number, %)

58

36.3

Activity daily living < 20 when admission (number, %)

92

57.5%

Laboratory data

 Neutrophil percentage (mean, SD)

83.42

12.37

 Lymphocyte percentage (mean, SD)

8.23

8.07

 Neutrophil to lymphocyte ratio (mean, SD)

20.90

23.90

Nasogastric tube use (number, %)

38

23.8%

Feeding gastrostomy or jejunostomy (number, %)

20

12.5%

Tracheostomy (number, %)

16

10%

Foley catheter use (number, %)

64

40%

Treatments when starting hospice ward admission

 Parenteral nutrition (number, %)

6

3.8%

 Antibiotic (number, %)

71

44.4%

 Oxygen (number, %)

136

85%

Treatments during hospice ward hospitalization

 Subcutaneous morphine use (number, %)

88

55%

 Total sedation (number, %)

4

2.5%

 Blood transfusion (number, %)

6

3.8%

 Parenteral nutrition (number, %)

3

1.9%